{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:52:57Z","timestamp":1763632377609,"version":"3.45.0"},"reference-count":62,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Slovenian Research Agency Programs","award":["P3-0308","P3-0154"],"award-info":[{"award-number":["P3-0308","P3-0154"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Peripheral arterial disease (PAD) is a growing global health concern associated with substantial morbidity, mortality, and healthcare costs. Prognostic stratification is currently based largely on clinical presentation, but patients with similar symptoms can have heterogeneous outcomes. Reliable biomarkers could improve the risk assessment of PAD patients and enable individualized patient management. High-sensitivity cardiac troponins (hs-cTn) and ischemia-modified albumin (IMA) have emerged as promising candidates. Hs-cTn appears to correlate with PAD severity and predict major adverse limb and cardiovascular events, likely reflecting subclinical myocardial injury in this patient population. Less extensively studied, IMA reflects oxidative stress, acidosis, and free radical activity. Its levels also seem to correlate with PAD severity, increasing with more advanced PAD. Notably, patients with advanced PAD but undetectable levels of biomarkers might have prognoses similar to those with milder disease, suggesting potential incremental prognostic value over clinical assessment. Despite these associations, the current applicability of hs-cTn and IMA remains limited by heterogeneous cut-off definitions and the absence of randomized controlled trials in the PAD population. Standardizing biomarker thresholds and prospective validation are crucial before integrating them into clinical practice. Both hs-cTn and IMA hold promise as tools for refined risk stratification in PAD, warranting further research.<\/jats:p>","DOI":"10.3390\/ijms262211214","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:44:53Z","timestamp":1763631893000},"page":"11214","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of High-Sensitivity Cardiac Troponin and Ischemia-Modified Albumin in Patients with Lower Extremity Peripheral Arterial Disease"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2171-7794","authenticated-orcid":false,"given":"Vinko","family":"Boc","sequence":"first","affiliation":[{"name":"Department of Vascular Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-1595","authenticated-orcid":false,"given":"Ale\u0161","family":"Blinc","sequence":"additional","affiliation":[{"name":"Department of Vascular Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6411-4344","authenticated-orcid":false,"given":"Anja","family":"Boc","sequence":"additional","affiliation":[{"name":"Department of Vascular Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia"},{"name":"Institute of Anatomy, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jvs.2022.12.015","article-title":"The Global Burden of Peripheral Artery Disease","volume":"77","author":"Eid","year":"2023","journal-title":"J. Vasc. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Luca, A.C., David, S.G., David, A.G., \u021aarc\u0103, V., P\u0103dure\u021b, I.A., M\u00eendru, D.E., Ro\u0219u, S.T., Ro\u0219u, E.V., Adumitr\u0103chioaiei, H., and Bernic, J. (2023). Atherosclerosis from Newborn to Adult-Epidemiology, Pathological Aspects, and Risk Factors. Life, 13.","DOI":"10.3390\/life13102056"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1016\/S2214-109X(23)00355-8","article-title":"Global burden of peripheral artery disease and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"11","author":"Kim","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2019.09.012","article-title":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review","volume":"293","author":"Agnelli","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1161\/ATVBAHA.120.314774","article-title":"Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis","volume":"40","author":"Kremers","year":"2020","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Saenz-Pipaon, G., Martinez-Aguilar, E., Orbe, J., Gonz\u00e1lez Miqueo, A., Fernandez-Alonso, L., Paramo, J.A., and Roncal, C. (2021). The Role of Circulating Biomarkers in Peripheral Arterial Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073601"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Poredo\u0161, P., \u0160abovi\u010d, M., Bo\u017ei\u010d Mijovski, M., Nikolajevi\u0107, J., Antignani, P.L., Paraskevas, K.I., Mikhailidis, D.P., and Blinc, A. (2022). Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231912054"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Khan, H., Girdharry, N.R., Massin, S.Z., Abu-Raisi, M., Saposnik, G., Mamdani, M., and Qadura, M. (2025). Current Prognostic Biomarkers for Peripheral Arterial Disease: A Comprehensive Systematic Review of the Literature. Metabolites, 15.","DOI":"10.3390\/metabo15040224"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10408369209105245","article-title":"Cardiac troponin T in the diagnosis of myocardial injury","volume":"29","author":"Mair","year":"1992","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16814641","DOI":"10.1016\/j.jacc.2006.02.056","article-title":"Biomarkers in acute cardiac disease: The present and the future","volume":"48","author":"Jaffe","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/01.CIR.83.3.902","article-title":"Diagnostic efficiency of troponin T measurements in acute myocardial infarction","volume":"83","author":"Katus","year":"1991","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1373\/clinchem.2011.165795","article-title":"Analytical characteristics of high-sensitivity cardiac troponin assays","volume":"58","author":"Apple","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrcardio.2013.129","article-title":"Cardiac troponin level elevations not related to acute coronary syndromes","volume":"10","author":"Giannitsis","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"Drazner","year":"2010","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1373\/clinchem.2016.264788","article-title":"High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2\u00b0P\u2014TIMI 50 Trial","volume":"63","author":"Eisen","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.atherosclerosis.2014.10.097","article-title":"High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study","volume":"237","author":"Pohlhammer","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jacc.2013.05.059","article-title":"Elevated cardiac troponin T is associated with higher mortality and amputation rates in patients with peripheral arterial disease","volume":"63","author":"Linnemann","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbacli.2015.06.003","article-title":"Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease","volume":"4","author":"Otaki","year":"2015","journal-title":"BBA Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-0035-1555133","article-title":"Coronary Artery Disease Severity and Cardiovascular Biomarkers in Patients with Peripheral Artery Disease","volume":"24","author":"Hikita","year":"2015","journal-title":"Int. J. Angiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00392-017-1185-z","article-title":"Myocardial injury after endovascular revascularization in critical limb ischemia predicts 1-year mortality: A prospective observational cohort study","volume":"107","author":"Szczeklik","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2019.04.061","article-title":"Cardiac biomarkers but not measures of vascular atherosclerosis predict mortality in patients with peripheral artery disease","volume":"495","author":"Clemens","year":"2019","journal-title":"Clin. Chim Acta"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cimaglia, P., Dalla Paola, L., Carone, A., Scavone, G., Manfrini, M., Brogneri, S., Tenti, E., Pavasini, R., Bernucci, D., and Passarini, G. (2021). High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients With Critical Limb Ischemia and Foot Lesions. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.595701"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rammos, C., Kontogiannis, A., Mahabadi, A.A., Steinmetz, M., Messiha, D., Lortz, J., and Rassaf, T. (2021). Risk stratification and mortality prediction in octo-and nonagenarians with peripheral artery disease: A retrospective analysis. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-02177-1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1024\/0301-1526\/a001170","article-title":"Prognostic value of biomarkers of ischaemia in patients with peripheral arterial disease following endovascular revascularisation","volume":"54","author":"Dobrilovic","year":"2025","journal-title":"Vasa"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamacardio.2020.2981","article-title":"Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines","volume":"5","author":"Marston","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_30","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1093\/eurheartj\/ehy106","article-title":"High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"39","author":"Matsushita","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amjcard.2019.11.019","article-title":"High Sensitivity Troponin and Risk of Incident Peripheral Arterial Disease in Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study)","volume":"125","author":"Janus","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2021.09.055","article-title":"Associations of cardiac injury biomarkers with risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis","volume":"344","author":"Garg","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/ATVBAHA.122.318774","article-title":"Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease","volume":"43","author":"Hicks","year":"2023","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0736-4679(00)00255-9","article-title":"A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report","volume":"19","author":"Lau","year":"2000","journal-title":"J. Emerg. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9945424","DOI":"10.1155\/2021\/9945424","article-title":"Ischemia-Modified Albumin: Origins and Clinical Implications","volume":"2021","author":"Shevtsova","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mangoni, A.A., and Zinellu, A. (2022). Serum Concentrations of Ischaemia-Modified Albumin in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11144205"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mangoni, A.A., and Zinellu, A. (2022). A Systematic Review and Meta-Analysis of Serum Concentrations of Ischaemia-Modified Albumin in Acute Ischaemic Stroke, Intracerebral Haemorrhage, and Subarachnoid Haemorrhage. Biomolecules, 12.","DOI":"10.3390\/biom12050653"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13017-023-00512-9","article-title":"Diagnostic accuracy of biomarkers to detect acute mesenteric ischaemia in adult patients: A systematic review and meta-analysis","volume":"18","author":"Starkopf","year":"2023","journal-title":"World J. Emerg. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/00033197221111860","article-title":"Oxidative Stress and Inflammation Markers Associated with Multiple Peripheral Artery Occlusions in Elderly Patients","volume":"74","author":"Li","year":"2023","journal-title":"Angiology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40200-022-01152-7","article-title":"Diagnostic values of ischemia modified albumin in diabetes-related complications: A narrative review","volume":"22","author":"Ghareghani","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gkana, A., Papadopoulou, A., Mermiri, M., Beltsios, E., Chatzis, D., Malli, F., Adamou, A., Gourgoulianis, K., Mavrovounis, G., and Pantazopoulos, I. (2022). Contemporary Biomarkers in Pulmonary Embolism Diagnosis: Moving beyond D-Dimers. J. Pers. Med., 12.","DOI":"10.3390\/jpm12101604"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1373\/clinchem.2004.031690","article-title":"Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia","volume":"50","author":"Roy","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejvs.2005.06.019","article-title":"Ischaemic skeletal muscle increases serum ischaemia modified albumin","volume":"31","author":"Troxler","year":"2006","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/CCLM.2006.038","article-title":"Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease","volume":"44","author":"Montagnana","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/emj.2007.051292","article-title":"Serum ischaemia-modified albumin increases in critical lower limb ischaemia","volume":"25","author":"Gunduz","year":"2008","journal-title":"Emerg. Med. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1590\/S1807-59322011001000003","article-title":"Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease","volume":"66","author":"Ma","year":"2011","journal-title":"Clinics"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Feng, F., Chen, Y., Wang, G., Huang, P., Zhu, Q., and Zhou, B. (2022). Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.846470"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/17085381221141473","article-title":"Evaluation of the relationship between adjusted ischemia-modified albumin and the presence and severity of peripheral artery disease","volume":"32","author":"Engin","year":"2024","journal-title":"Vascular"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MCA.0b013e3281ac2094","article-title":"Effects of peripheral vascular intervention on ischemia-modified albumin","volume":"18","author":"Hacker","year":"2007","journal-title":"Coron. Artery Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cca.2014.08.031","article-title":"Prognostic relevance of ischemia-modified albumin and NT-proBNP in patients with peripheral arterial occlusive disease","volume":"438","author":"Falkensammer","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.2337\/dc18-0695","article-title":"Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes","volume":"41","author":"Nativel","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision Medicine, AI, and the Future of Personalized Health Care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_54","first-page":"33","article-title":"Advancing precision medicine: The transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization","volume":"22","author":"Chang","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"ref_55","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.117.029901","article-title":"D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study","volume":"138","author":"Simes","year":"2018","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Surma, S., and Banach, M. (2021). Fibrinogen and Atherosclerotic Cardiovascular Diseases-Review of the Literature and Clinical Studies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010193"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1358863X10373299","article-title":"Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry","volume":"15","author":"Zeymer","year":"2010","journal-title":"Vasc. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e1324","DOI":"10.1002\/iid3.1324","article-title":"Ischemia-modified albumin in rheumatic diseases: A systematic review and meta-analysis","volume":"12","author":"Mangoni","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta-Analysis of Mortality and Disease Progression in Peripheral Arterial Disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11214\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:50:13Z","timestamp":1763632213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":62,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262211214"],"URL":"https:\/\/doi.org\/10.3390\/ijms262211214","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}